CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities:
Net income	$ 10,319	$ 7,179
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,358	2,009
Amortization on right-of-use assets	1,644	1,922
Provision for bad debts	822	2,825
Deferred income tax – net	2,437	1,962
Compensatory element of stock issuances		83
Stock issued for costs and expenses		1,941
Abandoned patents		1
Gain on forgiveness of PPP loan	(701)
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(2,429)	(5,549)
Notes receivable	22	25
Inventories	(436)	(195)
Income tax receivable		671
Prepaid expenses and other current assets	(33)	452
Other assets	102	(1)
Increase (decrease) in operating liabilities, net:
Accounts payable	(1,090)	233
Other current liabilities	(5,395)	(2,748)
Operating lease liabilities	(1,414)	(1,657)
Financing lease liabilities	(101)	24
Customer deposits	(277)	378
Other liabilities	(33)	(3)
Net cash provided by operating activities	5,795	9,552
Cash Flows from Investing Activities:
Purchases of property and equipment	(2,106)	(2,143)
Purchase of noncontrolling interests	(546)
Cost of patents	(38)	(90)
Net cash used in investing activities	(2,690)	(2,233)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(13)	(35)
Proceeds from debt		63
Distributions to noncontrolling interests	(2,701)	(3,570)
Net cash used in financing activities	(2,714)	(3,542)
Net Increase in Cash and Cash Equivalents	391	3,777
Cash and Cash Equivalents - Beginning of Period	44,460	36,802
Cash and Cash Equivalents - End of Period	$ 44,851	$ 40,579